Clinical Trial

Blood and imagE-guided Optimization of Neoadjuvant Therapy in People With Early Stage Triple-negative Breast cancER - the BETTER Trial

Name: Blood and imagE-guided Optimization of Neoadjuvant Therapy in People With Early Stage Triple-negative Breast cancER - the BETTER Trial — clinical trial record (NCT07610525)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

To learn whether certain blood and imaging tests can show which people with early-stage TNBC may already have had a complete response to chemotherapy before they go to surgery.

Trial Details

NCT Number	NCT07610525
Lead Sponsor	M.D. Anderson Cancer Center
Conditions	Triple Negative Breast Cancer, Blood and Image Guided, Optimization of Neoadjuvant Therapy, Phase 2
Enrollment	200 participants
Start Date	2026-11-05
Primary Completion	2029-01-15 (estimated)
Study Completion	2031-01-15 (estimated)
Updated on ClinicalTrials.gov	2026-05-28